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Abstract The structure of the native zinc form of the DNA 
binding domain in the yeast transcriptional activator PPR1 was 
investigated by extended X-ray absorption fine structure 
(EXAFS). By carrying out the EXAFS measurements at l l k  we 
were able to demonstrate xplicitly the proximity of the two zinc 
ions (Zn-Zn distance = 3.16 + 0.03 A) and the presence of bridg- 
ing cysteine ligands. The results show that the six cysteine resi- 
dues co-ordinate two zinc ions in a two-metal ion cluster. PPR1 
is the first member of this class of protein for which such informa- 
tion has been obtained. 
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it contains two zinc ions per protein molecule. EXAFS studies 
confirmed that the native zinc form of PPR 1 contains a Zn2Cy% 
two metal ion cluster, of the type reported for Cd(II) GAL4 
[9-12]. 
2. Materials and methods 
2.1. Protein purification 
The Zn(II)-PPRI(1-118) fragment was purified using a modified 
version of the procedure described by Gadhavi et al. [13]; improved 
resolution was obtained using a Superdex 30 gel filtration column 
(Pharmacia) instead of the S-100 gel filtration column for the second 
step of the purification. Protein for EXAFS was concentrated to ~ 1 mM 
in the presence of 80 pM ZnClz. All protein concentrations were deter- 
mined by amino acid analysis. 
I. Introduction 
The PPR1 (pyrimidine pathway regulatory 1) protein acti- 
vates the expression of the URAI  and URA3 genes involved 
in the pyrimidine biosynthetic pathway of the yeast Saccharo- 
myces cerevisiae [1-3]. PPR1 recognises and binds co-opera- 
tively to a specific 12 base pair DNA sequence present within 
the upstream activating sequence for uracil (UAS,) [4]. It be- 
longs to a class of gene regulatory proteins that all contain a 
highly conserved cysteine-rich sequence (Cys-Xz-Cys-X6-Cys- 
X6-Cys-X2-Cys-X6-Cys ) within their DNA binding domains 
[5,6]. In GAL4, the most highly studied of these proteins, this 
region has been shown to bind two atoms of either zinc or 
cadmium per molecule of protein [7,8]. Furthermore, the cad- 
mium substituted form of GAL4 has been shown by two-di- 
mensional 1H-ll3Cd NMR experiments to contain a two metal 
ion cluster of the type Cd2fys6 [9]. Subsequent structure deter- 
mination and comparisons between the NMR spectra of Cd(II) 
and Zn(II) GAL4 suggested that the native zinc form contained 
an analogous cluster [10,11]. However, NMR spectroscopy 
cannot readily be used to determine direct connectivities to 
zinc, so unambiguous proof of these structures using NMR is 
difficult. In principle EXAFS should allow such proof, but our 
previous work on Zn(II) GAL4 yielded ambiguous results [8]. 
Here we report the results of both electrospray ionisation 
mass spectrometry (El-MS) and low temperature EXAFS stud- 
ies on the native zinc form of a fragment of PPR1, Zn(II)- 
PPRI(1-118), which contains the UAS u DNA binding domain. 
After purification of the DNA binding domain of PPR1 from 
an over-expressing strain of E. coli, EI-MS studies showed that 
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2.2. Gel retardation assays 
Gel retardation assays were carried out on an 8% acrylamide gel, 
using 45 mM Tris-borate (pH 8.3) as the running buffer. The PPR1 
UASu binding site was labelled at the 5' end using ~,-32p-labelled ATP 
[14]. Varying concentrations of PPRI(1 118) were incubated with the 
labelled binding site in a buffer containing 10 mM HEPES, 100 mM 
NaC1, 5 mM MgC12, 20 mM ZnClz and 10% (v/v) glycerol. All incuba- 
tions were carried out in the presence of a ten-fold excess of poly(dI- 
dC). 
2.3. Electrospray ionisation mass pectrometry (El-MS) 
EI-MS was carried out using a Bio-Q quadrupole mass spectrometer 
(VG Mass Lab Ltd.). The delivery solvent consisted of a mixture of 50% 
(v/v) acetonitrile in water; the flow was 2-4/zl/min and positive ions 
were detected. Calibrations were performed on myoglobin for the mass/ 
charge (m/z) range 500-2000. The cone extraction voltage (B 1) was set 
to 80 V. Each sample (- 10/11) contained 50% (v/v) methanol and 20-50 
pmol/pl of protein. 
Samples of the metallo form of the protein, Zn(II)-PPRI(I 118), 
were prepared as stated above. To obtain apo-PPRl(1 118), the metal 
ions were removed by reversed-phase HPLC on a Ct8 column using a 
water/acetonitrile gradient containing 0.1% TFA. All spectra were re- 
corded in multiple scan acquisition mode, and molecular weights were 
determined using the manufacturer's software. 
2.4. EXAFS studies 
X-Ray absorption spectra were recorded over the energy range cor- 
responding to the Zn K-edge, as fluorescence xcitation spectra. The 
data were obtained on a Wiggler beamline using station 9.2 of the 
Synchotron Radiation Source at Daresbury Laboratory. The electron 
storage ring operated at 2 GeV with an average current of 150 mA. 
Harmonic ontamination was minimised by employing a double crystal 
Si (220) monochromator [15]. An array of 12 germanium solid state 
detectors with individual electronics [16] were used to monitor the 
X-ray fluorescence excitation spectra. A total of 20 one-hour scans were 
recorded for a 1 mM sample of PPRI(I-118) in a solution of 80/zM 
ZnCI2 at pH 5.5 which was frozen and maintained at 1 lk by an APD 
DE204SL closed cycle cryostat. Prior to averaging the data, spectra 
from each germanium detector were weighted according to the edge 
height. Any spectrum showing irregularities was omitted from the aver- 
aging process. 
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The isolated EXAFS data for PPR1 were analysed over the range 
2.75<K<12.75 A -~ using EXCURVE90 [17], employing the single 
scattering spherical wave method for EXAFS calculations. Phase shifts 
were obtained from ab initio calculations as described previously 
[18,19]. As an aid to the interpretation f the PPR 1 data, corresponding 
X-ray absorption spectra were recorded in transmission mode at 1 lk 
for model compounds of known structure, [PPh4]z[Zn2(SPh)6] [20] and 
[NMe4]2[Zn4(SPh)~0] [21], from powdered samples diluted with 
graphite. 
3. Results 
We initially used limited proteolysis of a fragment of the 
PPR1 protein, residues 1-143 (PPRI(1 143)), in an attempt to 
define the domain structure within the DNA binding region 
(Griffiths and Gadhavi, unpublished results). Gel retardation 
assays of several smaller fragments of the DNA binding domain 
showed that a fragment consisting of residues 1 118 bound 
specifically to a consensus 12 base pair DNA binding site, 
whereas maller fragments did not. However, the larger frag- 
ment PPRl(1-143), was seen to bind somewhat more strongly 
and at lower protein concentrations (data not shown). Fig. 1 
shows a gel retardation assay of Zn(II) PPRI(1-118) in the 
presence of its cognate DNA and an excess of poly(dI-dC); the 
PPR1-UAS u complex can be seen at a protein concentration f 
2.5/.tM. Mass spectra of the apo and the metallo forms of 
Zn(II) PPRI(1-118) showed a mass difference between the two 
forms equivalent tothat of two zinc atoms, confirming that this 
DNA binding domain binds two molecules of zinc (see Fig. 2). 
EXAFS was employed to probe the immediate environment 
of the zinc ions in PPR1 and the two model compounds. This 
technique provides information on the number and types of 
ligands and their distances from the atom being probed. The 
measurements were carried out at a temperature of 1 lk so as 
to minimise thermal disorder in the sample, thereby enhancing 
the EXAFS signal. Phase shifts and the calculation procedures 
were checked using the model compounds. From the EXAFS 
data of the model compounds and their Fourier transforms ( ee 
Fig. 3) it is clear that scattering from multiple shells is respon- 
sible for the data, which are best fitted with a combination of
Zn S and Zn-Zn components. The first shell, due to Zn-S, was 
further sub-divided for both model compounds into two shells, 
thus providing an improved simulation of the experimental 
data. When the data were fitted to a single shell of sulphur 
atoms a large Debye-Waller type factor was obtained. As the 
EXAFS data were collected at a temperature of 1 lk, the atoms 
should have little thermal motion, so the higher than expected 
value for the Debye-Waller type factor could be attributed to 
static disorder. The final theoretical EXAFS simulations agree 
well with the crystal structures of the two model compounds 
and also reveal different Zn S bond distances for the terminal 
(shorter distance) and bridging Zn-S bonds (see Table 1), thus 
providing us with confidence in the refinement procedure. 
For Zn(II) PPR1, the EXAFS data and subsequent Fourier 
transforms ( ee Fig. 3) also show that there are contributions 
from two shells of atoms. The initial fit was to four sulphur 
atoms at 2.32 A and a zinc atom at 3.16 A. Again the Debye- 
Waller type factor for the single shell of sulphur atoms was 
large and it was consequently split into two shells each contain- 
ing two sulphur atoms. The bond distances were allowed to 
float and the best fit was found with two sulphur atoms at 2.28 
A and two at 2.41 A (the estimated error in the distances 
PPR1-DNA complex 
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Fig. 1. Gel retardation assay showing that PPRI(1 118) binds equence 
specifically to the UASu binding site, in the presence of an excess of 
non-specific poly(dI-dC). Lane 1 contains free DNA and lanes 24 
contain DNA plus PPR1 (1-118) at concentrations of 2.5 ¢tM, 0.25/~M 
and 0.025 BM respectively. At the protein concentration f 2.5 ,uM, a 
single band due to complex formation is clearly visible. 
determined by analysis of the EXAFS data is + 0.03 A). The 
second shell was fitted with a zinc atom at 3.16 A. This was 
confirmed by Fourier filtering the peak in the transformed data 
and then fitting it with both zinc and sulphur. The fit index for 
zinc was 0.038 whilst for sulphur it was 0.090, suggesting that 
the second shell was indeed ue to a zinc atom. The results are 
in agreement with the structure of the cadmium substituted 
form of the sister protein GAL4 as determined by NMR spec- 
troscopy and X-ray diffraction [10-12]. 
4. Discussion 
A combination of deletion analysis and probing of the do- 
main structure using limited proteolysis experiments was used 
to define the minimal DNA binding domain of PPR1. Gel 
retardation analysis showed that the native Zn(II) form of 
residues 1-118 of PPR1 binds specifically to DNA and El-MS 
showed that it contains two zinc ions per molecule of protein. 
In our original studies ofCd(II) GAL4 we were able to show, 
by 2D IH-ll3Cd NMR spectroscopy, that the six cysteine resi- 
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Fig. 2. Mass spectra of (a) apo PPR 1 (1-118) purified by reversed-phase (C,8) HPLC, to remove the metal ions, and (b) native Zn(II)-PPR 1 (1-118). 
The peaks labelled [A + n] "÷ denote the net charge (n) of the apo (A) form and [M + n] "+ the net charge of the metallo (M) form of the protein. The 
spectra show clearly that two zinc ions are present per molecule of protein in the native metallo form. 
dues co-ordinate the cadmium ions in a two metal ion cluster. 
Given the similar DNA binding affinities and ~H NMR spectra 
of the Cd(II) and Zn(II) forms of GAL4, it was possible to infer 
that the native zinc form of GAL4 contained the same struc- 
ture. The results reported here from the EXAFS studies of the 
closely homologous PPR1 protein show that this is correct. We 
propose that the two zinc ions are each co-ordinated by four 
sulphurs, two from terminal and two from bridging cysteines, 
in an arrangement (see Fig. 4) which corresponds to that iden- 
tified for the [Zn2(SR)6] 2- (R = Et [22] or Ph [20,23]) anions. The 
L.J. Ball et al./FEBS Letters 358 (1995) 278-282 281 
IM 
20 
15 
~0 
-5 
I I ! I I i 5.5 I I I I I l 
3.0 
2.5 
"D 
= 2.0 
~ 1.5 
1.0 
0.5 
0.0 
~ _  (i)_ --. 
(ii) 
-10  
I I I I I I I I I I I I I 
2 4 6 8 ~0 ~2 ~4 ~6 0 ~ 2 s 4 s 6 
a k (A -1) b R (/~) 
Fig. 3. (a) Zn-K edge EXAFS of (i) PPR1 (ii) [Zn2(SPh)6][PPh4]2 and (iii) [Zn4(SPh)I0][NMe4]2. Continuous lines represent the experimental spectra, 
broken lines the simulated spectra. (b) Fourier transforms of the EXAFS data from Fig. 3a, where continuous lines represent experimental spectra 
and broken lines simulated spectra, of (i) PPRI, (ii) [Zn2(SPh)d[PPh4]2 and (iii) [Zn4(SPh)t0][NMe4]2. The Fourier transform ranges were 2.5-12.75, 
2.5-16.0 and 2.5-16.0/~-~, respectively. 
Zn-Zn separation identified for PPR1 of 3.16/~ is in particu- 
larly good agreement with that of  3.18/~ in [Zn2(SEt)6] 2, consis- 
tent with the zinc ions being bridged by two alkyl thiolates in 
each case. Also, the pattern of the Zn-S  distances obtained for 
PPR1 is the same as that obtained for the [Zn2(SR)6] 2- anions, 
in which the terminal and bridging Zn-S  bonds are ca. 2.30 and 
2.43 A respectively [20,22,23]. These results clearly suggest hat 
each monomer  of the Zn(I I)  form of  PPR 1 contains a bimettalic 
cluster, in which each zinc ion is tetrahedrally co-ordinated by 
four cysteine residues, two of which act as bridging ligands 
between the two neighbouring zinc atoms (see Fig. 4). 
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Table 1 
Samples and methods No. of atoms Zn-S distance No. of atoms Zn-S distance No. of atoms Zn-Zn distance 
(A)" (A)" (A)" 
PPR1 
EXAFS b 2 2.28 2 2.41 1 3.16 
0-2 = 0.001 0 -2 = 0.002 0-2 = 0.005 
[ ( PPh4) ]e[ Zne( SPh )6] 
EXAFS b 
X-ray diffraction [21] 
[NMe4]e[Zn4(SPh) ,o]
EXAFS b 
X-ray diffraction [21] 
2 2.29 2 2.41 1 3.35 
cr 2 = 0.025 cr 2 = 0.004 0 .2 = 0.007 
2 2.30 2 2.43 1 3.42 
1 2.28 3 2.37 3 3.97 
0-2 = 0.0005 0-2 = 0.0025 a 2 = 0.0055 
1 2.29 3 2.37 3 3.98 
a For the EXAFS data the Debye Waller type factor a z, obtained in the final fit, is also quoted. 
bThe estimated error in the distances determined by analysis of the EXAFS data is +0.03 A. 
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Fig. 4. Schematic representation f the zinc cluster in the DNA binding 
domain of PPR 1. Bond lengths to terminal (a) and bridging (b) sulphur 
atoms (obtained from the EXAFS data) are marked on the diagram and 
the metal metal separation is 3.16 A. These values are in good agree- 
ment with those obtained for the two metal ion cluster observed in 
Cd(II) GAL4 [21]. 
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